Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bonomo

Showing results (101-110 of 884) with videos related to

Pageof 89
Sort By:
Expert Review of Anti-Infective Therapy|July 26, 2016
On the path to untreatable infections: colistin use in agriculture and the end of 'last resort' antibioticsRichard R Watkins, Tara C Smith, Robert A Bonomo
FEMS Microbiology Letters|March 1, 1997
Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamasesR A Bonomo, S A Rudin, D M Shlaes
Annual Review of Medicine|February 8, 2018
New Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial ResistanceEphraim L Tsalik, Robert A Bonomo, Vance G Fowler
Australian Journal of Primary Health|August 5, 2022
Use of electronic medical records to monitor the safe and effective prescribing of medicinal cannabis: is it feasible?Christine M Hallinan, Jane M Gunn, Yvonne A Bonomo
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 15, 2002
Rapid method of extraction and analysis of extended-spectrum beta-lactamases from clinical strains of Klebsiella pneumoniaeD L Paterson, L B Rice, R A Bonomo
FEMS Microbiology Letters|July 15, 1997
OHIO-1 beta-lactamase mutants: Asp179Gly mutation confers resistance to ceftazidimeR A Bonomo, S D Rudin, D M Shlaes
FEMS Microbiology Letters|April 1, 1992
OHIO-1 beta-lactamase resistant to mechanism-based inactivatorsR A Bonomo, C Currie-McCumber, D M Shlaes
Biochemistry|September 13, 2007
Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244Jodi M Thomson, Anne M Distler, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2015
Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threatPaul J Lukac, Robert A Bonomo, Latania K Logan
The Journal of Antimicrobial Chemotherapy|May 10, 2015
Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loopMarisa L Winkler, Krisztina M Papp-Wallace, Robert A Bonomo
Pageof 89

Showing results (101-110 of 884) with videos related to

Sort By:
Pageof 89
Expert Review of Anti-Infective Therapy|July 26, 2016
On the path to untreatable infections: colistin use in agriculture and the end of 'last resort' antibioticsRichard R Watkins, Tara C Smith, Robert A Bonomo
FEMS Microbiology Letters|March 1, 1997
Tazobactam is a potent inactivator of selected inhibitor-resistant class A beta-lactamasesR A Bonomo, S A Rudin, D M Shlaes
Annual Review of Medicine|February 8, 2018
New Molecular Diagnostic Approaches to Bacterial Infections and Antibacterial ResistanceEphraim L Tsalik, Robert A Bonomo, Vance G Fowler
Australian Journal of Primary Health|August 5, 2022
Use of electronic medical records to monitor the safe and effective prescribing of medicinal cannabis: is it feasible?Christine M Hallinan, Jane M Gunn, Yvonne A Bonomo
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|February 15, 2002
Rapid method of extraction and analysis of extended-spectrum beta-lactamases from clinical strains of Klebsiella pneumoniaeD L Paterson, L B Rice, R A Bonomo
FEMS Microbiology Letters|July 15, 1997
OHIO-1 beta-lactamase mutants: Asp179Gly mutation confers resistance to ceftazidimeR A Bonomo, S D Rudin, D M Shlaes
FEMS Microbiology Letters|April 1, 1992
OHIO-1 beta-lactamase resistant to mechanism-based inactivatorsR A Bonomo, C Currie-McCumber, D M Shlaes
Biochemistry|September 13, 2007
Overcoming resistance to beta-lactamase inhibitors: comparing sulbactam to novel inhibitors against clavulanate resistant SHV enzymes with substitutions at Ambler position 244Jodi M Thomson, Anne M Distler, Robert A Bonomo
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 18, 2015
Extended-spectrum β-lactamase-producing Enterobacteriaceae in children: old foe, emerging threatPaul J Lukac, Robert A Bonomo, Latania K Logan
The Journal of Antimicrobial Chemotherapy|May 10, 2015
Activity of ceftazidime/avibactam against isogenic strains of Escherichia coli containing KPC and SHV β-lactamases with single amino acid substitutions in the Ω-loopMarisa L Winkler, Krisztina M Papp-Wallace, Robert A Bonomo
Pageof 89